Challenges for the therapeutic use of pluripotent stem derived cells

Frontiers in Physiology

Volumn 3 FEB, Issue , 2012, Pages

  Forsberg, Magda ^a   Hovatta, Outi ^a  

^a KAROLINSKA INSTITUTE   (Sweden)

Author keywords

Cell transplantation; Gmp; Human embryonic stem cells; Human pluripotent stem cells; Immunoreactivity; Tumorigenic

Indexed keywords

EID: 84864586857     PISSN: None     EISSN: 1664042X     Source Type: Journal    
DOI: 10.3389/fphys.2012.00019     Document Type: Short Survey

References (44)

1. Amps, K., Andrews, P. W., Anyfantis, G., Armstrong, L., Avery, S., Baharvand, H., Baker, J., Baker, D., Munoz, M. B., Beil, S., Benvenisty, N., BenYosef, D., Biancotti, J. C., Bosman, A., Brena, R. M., Brison, D., Caisander, G., Camarasa, M. V., Chen, J., Chiao, E., Choi, Y. M., Choo, A. B., Collins, D., Colman, A., Crook, J. M., Daley, G. Q., Dalton, A., De Sousa, P. A., Denning, C., Downie, J., Dvorak, P., Montgomery, K. D., Feki, A., Ford, A., Fox, V., Fraga, A. M., Frumkin, T., Ge, L., Gokhale, P. J., Golan-Lev, T., Gourabi, H., Gropp, M., Guangxiu, L., Hampl, A., Harron, K., Healy, L., Herath, W., Holm, F., Hovatta, O., Hyllner, J., Inamdar, M. S., Irwanto, A. K., Ishii, T., Jaconi, M., Jin, Y., Kimber, S., Kiselev, S., Knowles, B. B., Kopper, O., Kukharenko, V., Kuliev, A., Lagarkova, M. A., Laird, P. W., Lako, M., Laslett, A. L., Lavon, N., Lee, D. R., Lee, J. E., Li, C., Lim, L. S., Ludwig, T. E., Ma, Y., Maltby, E., Mateizel, I., Mayshar, Y., Mileikovsky, M., Minger, S. L., Miyazaki, T., Moon, S. Y., Moore, H., Mummery, C., Nagy, A., Nakatsuji, N., Narwani, K., Oh, S. K., Oh, S. K., Olson, C., Otonkoski, T., Pan, F., Park, I. H., Pells, S., Pera, M. F., Pereira, L. V., Qi, O., Raj, G. S., Reubinoff, B., Robins, A., Robson, P., Rossant, J., Salekdeh, G. H., Schulz, T. C., Sermon, K., Sheik Mohamed, J., Shen, H., Sherrer, E., Sidhu, K., Sivarajah, S., Skottman, H., Spits, C., Stacey, G. N., Strehl, R., Strelchenko, N., Suemori, H., Sun, B., Suuronen, R., Takahashi, K., Tuuri, T., Venu, P., Verlinsky, Y., Ward-van Oostwaard, D., Weisenberger, D. J., Wu, Y., Yamanaka, S., Young, L., and Zhou, Q. (2011). Screening ethnically diverse human embryonic stem cells identifies a chromosome 20 minimal amplicon conferring growth advantage. Nat. Biotechnol. 29, 1132-1144.
2. Ausubel, L. J., Lopez, P. M., and Couture, L. A. (2011). GMP scale-up and banking of pluripotent stem cells for cellular therapy applications. Methods Mol. Biol. 767, 147-159.
3. Dhodapkar, K. M., Feldman, D., Matthews, P., Radfar, S., Pickering, R., Turkula, S., Zebroski, H., and Dhodapkar, M. V. (2010). Natural immunity to pluripotency antigen OCT4 in humans. Proc. Natl. Acad. Sci. U.S.A. 107, 8718-8723.
4. Doi, A., Park, I. H., Wen, B., Murakami, P., Aryee, M. J., Irizarry, R., Herb, B., Ladd-Acosta, C., Rho, J., Loewer, S., Miller, J., Schlaeger, T., Daley, G. Q., and Feinberg, A. P. (2009). Differential methylation of tissue and cancer-specific CpG island shores distinguishes human induced pluripotent stem cells, embryonic stem cells and fibroblasts. Nat. Genet. 41, 1350-1353.
5. Drobyski, W. R., Gendelman, M., Vodanovic-Jankovic, S., and Gorski, J. (2003). Elimination of leukemia in the absence of lethal graft versus-host disease after allogenic bone marrow transplantation. J. Immunol. 170, 3046-3053.
6. Drukker, M., and Benvenisty, N. (2004). The immunogenicity of human embryonic stem-derived cells. Trends Biotechnol. 22, 136-141.
7. Drukker, M., Katchman, H., Katz, G., Even-Tov Friedman, S., Shezen, E., Hornstein, E., Mandelboim, O., Reisner, Y., and Benvenisty, N. (2006). Human embryonic stem cells and their differentiated derivatives are less susceptible to immune rejection than adult cells. Stem Cells 24, 221-229.
8. Drukker, M., Katz, G., Urbach, A., Schuldiner, M., Markel, G., Itskovitz Eldor, J., Reubinoff, B., Mandelboim, O., and Benvenisty, N. (2002). Characterization of the expression of MHC proteins in human embryonic stem cells. Proc. Natl. Acad. Sci. U.S.A. 99, 9864-9869.
9. Gore, A., Li, Z., Fung, H. L., Young, J. E., Agarwal, S., Antosiewicz-Bourget, J., Canto, I., Giorgetti, A., Israel, M. A., Kiskinis, E., Lee, J. H., Loh, Y. H., Manos, P. D., Montserrat, N., Panopoulos, A. D., Ruiz, S., Wilbert, M. L., Yu, J., Kirkness, E. F., Izpisua Belmonte, J. C., Rossi, D. J., Thomson, J. A., Eggan, K., Daley, G. Q., Goldstein, L. S., and Zhang, K. (2011). Somatic coding mutations in human induced pluripotent stem cells. Nature 471, 63-67.
10. Grinnemo, K. H., Genead, R., Kumagai Braesch, M., Andersson, A., Danielsson, C., Mansson-Broberg, A., Dellgren, G., Stromberg, A. M., Ekberg, H., Hovatta, O., Sylven, C., and Corbascio, M. (2008). Costimulation blockade induces tolerance to HESC transplantedtothetestisandinduces regulatory T-cells to HESC transplanted into the heart. Stem Cells 26, 1850-1857.
11. Grinnemo, K. H., Kumagai-Braesch, M., Mansson-Broberg, A., Skottman, H., Hao, X., Siddiqui, A., Andersson, A., Stromberg, A. M., Lahesmaa, R., Hovatta, O., Sylven, C., Corbascio, M., and Dellgren, G. (2006). Human embryonic stem cells are immunogenic in allogeneic and xenogeneic settings. Reprod. Biomed. Online 13, 712-724.
12. Gutierrez-Dalmau, A., and Campistol, J. M. (2007). Immunosuppressive therapy and malignancy in organ transplant recipients: a systematic review. Drugs 67, 1167-1198.
13. Hisamatsu-Sakamoto, M., Sakamoto, N., and Rosenberg, A. S. (2008). Embryonic stem cells cultured in serum-free medium acquire bovine apolipoprotein B-100 from feeder cell layers and serum replacement medium. Stem Cells 26, 72-78.
14. Hovatta, O. (2011). Infectious problems associated with transplantation of cells differentiated from pluripotent stem cells. Semin. Immunopathol. 33, 627-630.
15. Hovatta, O., Mikkola, M., Gertow, K., Stromberg, A. M., Inzunza, J., Hreinsson, J., Rozell, B., Blennow, E., Andang, M., and Ahrlund-Richter, L. (2003). A culture system using human foreskin fibroblasts as feeder cells allows production of human embryonic stem cells. Hum. Reprod. 18, 1404-1409.
16. Hussein, S. M., Batada, N. N., Vuoristo, S., Ching, R. W., Autio, R., Narva, E., Ng, S., Sourour, M., Hamalainen, R., Olsson, C., Lundin, K., Mikkola, M., Trokovic, R., Peitz, M., Brustle, O., Bazett-Jones, D. P., Alitalo, K., Lahesmaa, R., Nagy, A., and Otonkoski, T. (2011). Copy number variation and selection during reprogramming to pluripotency. Nature 471, 58-62.
17. Ilic, D., Stephenson, E., Wood, V., Jacquet, L., Stevenson, D., Petrova, A., Kadeva, N., Codognotto, S., Patel, H., Semple, M., Cornwell, G., Ogilvie, C., and Braude, P. (2012). Derivation and feeder-free propagation of human embryonic stem cells under xeno-free conditions. Cytotherapy 14, 122-128.
18. Kim, K., Doi, A., Wen, B., Ng, K., Zhao, R., Cahan, P., Kim, J., Aryee, M. J., Ji, H., Ehrlich, L. I., Yabuuchi, A., Takeuchi, A., Cunniff, K. C., Hongguang, H., Mckinney Freeman, S., Naveiras, O., Yoon, T. J., Irizarry, R. A., Jung, N., Seita, J., Hanna, J., Murakami, P., Jaenisch, R., Weissleder, R., Orkin, S. H., Weissman, I. L., Feinberg, A. P., and Daley, G. Q. (2010). Epigenetic memory in induced pluripotent stem cells. Nature 467, 285-290.
19. Kriks, S., Shim, J. W., Piao, J., Ganat, Y. M., Wakeman, D. R., Xie, Z., Carrillo-Reid, L., Auyeung, G., Antonacci, C., Buch, A., Yang, L., Beal, M. F., Surmeier, D. J., Kordower, J. H., Tabar, V., and Studer, L. (2011). Dopamine neurons derived from human ES cells efficiently engraft in animal models of Parkinson's disease. Nature 480, 547-551.
20. Lechler, R. I., Sykes, M., Thomson, A. W., and Turka, L. A. (2005). Organ transplantation - how much of the promise has been realized? Nat. Med. 11, 605-613.
21. Li, L., Baroja, M. L., Majumdar, A., Chadwick, K., Rouleau, A., Gallacher, L., Ferber, I., Lebkowski, J., Martin, T., Madrenas, J., and Bhatia, M. (2004). Human embryonic stem cells possess immuneprivileged properties. Stem Cells 22, 448-456.
22. Li, S. C., and Zhong, J. F. (2009). Twisting immune responses for allogeneic stem cell therapy. World J. StemCells 1, 30-35.
23. Lister, R., Pelizzola, M., Kida, Y. S., Hawkins, R. D., Nery, J. R., Hon, G., Antosiewicz-Bourget, J., O'malley, R., Castanon, R., Klugman, S., Downes, M., Yu, R., Stewart, R., Ren, B., Thomson, J. A., Evans, R. M., and Ecker, J. R. (2011). Hotspots of aberrant epigenomic reprogramming in human induced pluripotent stem cells. Nature 471, 68-73.
24. Ludwig, T. E., Levenstein, M. E., Jones, J. M., Berggren, W. T., Mitchen, E. R., Frane, J. L., Crandall, L. J., Daigh, C. A., Conard, K. R., Piekarczyk, M. S., Llanas, R. A., and Thomson, J. A. (2006). Derivation of human embryonic stem cells in defined conditions. Nat. Biotechnol.24,185-187. Martin, M. J., Muotri, A., Gage, F., and Varki, A. (2005). Human embryonic stem cells express an immunogenic nonhuman sialic acid. Nat. Med. 11, 228-232.
25. Mikkelsen, T. S., Hanna, J., Zhang, X., Ku, M., Wernig, M., Schorderet, P., Bernstein, B. E., Jaenisch, R., Lander, E. S., and Meissner, A. (2008). Dissecting direct reprogramming through integrative genomic analysis. Nature 454, 49-55.
26. Ohm, J. E., Mali, P., Van Neste, L., Berman, D. M., Liang, L., Pandiyan, K., Briggs, K. J., Zhang, W., Argani, P., Simons, B., Yu, W., Matsui, W., Van Criekinge, W., Rassool, F. V., Zambidis, E., Schuebel, K. E., Cope, L., Yen, J., Mohammad, H. P., Cheng, L., and Baylin, S. B. (2010). Cancer-related epigenome changes associated with reprogramming to induced pluripotent stem cells. Cancer Res. 70, 7662-7673.
27. Okita, K., Ichisaka, T., and Yamanaka, S. (2007). Generation of germline competent induced pluripotent stem cells. Nature 448, 313-317.
28. Okita, K., Nagata, N., and Yamanaka, S. (2011). Immunogenicity of induced pluripotent stem cells. Circ. Res. 109, 720-721.
29. Pearl, J. I., Lee, A. S., Leveson Gower, D. B., Sun, N., Ghosh, Z., Lan, F., Ransohoff, J., Negrin, R. S., Davis, M. M., and Wu, J. C. (2011). Short-term immunosuppression promotes engraftment of embryonic and induced pluripotent stem cells. Cell Stem Cell 8, 309-317. Pera, M. F. (2011). Stem cells: the dark side of induced pluripotency. Nature 471, 46-47.
30. Petersen, V. P., Olsen, T. S., Kissmeyer Nielsen, F., Bohman, S. O., Hansen, H. E., Hansen, E. S., Skov, P. E., and Solling, K. (1975). Late failure or human renal transplants. An analysis of transplant disease and graft failure among 125 recipients surviving for one to eight years. Medicine (Baltimore) 54, 45-71.
31. Rajala, K., Lindroos, B., Hussein, S. M., Lappalainen, R. S., Pekkanen Mattila, M., Inzunza, J., Rozell, B., Miettinen, S., Narkilahti, S., Kerkela, E., Aalto-Setala, K., Otonkoski, T., Suuronen, R., Hovatta, O., and Skottman, H. (2010). A defined and xeno-free culture method enabling the establishment of clinical-grade human embryonic, induced pluripotent and adipose stem cells. PLoS ONE 5, e10246. doi:10.1371/journal.pone.0010246
32. Reubinoff, B. E., Pera, M. F., Fong, C. Y., Trounson, A., and Bongso, A. (2000). Embryonic stem cell lines from human blastocysts: somatic differentiation in vitro. Nat. Biotechnol. 18, 399-404.
33. Rodin, S., Domogatskaya, A., Strom, S., Hansson, E. M., Chien, K. R., Inzunza, J., Hovatta, O., and Tryggvason, K. (2010). Long-term self-renewal of human pluripotent stem cells on human recombinant laminin-511. Nat. Biotechnol. 28, 611-615.
34. Sidhu, K. S., Walke, S., and Tuch, B. E. (2008). Derivation and propagation of hESC under a therapeutic environment. Curr. Protoc. Stem Cell Biol. Chapter 1, Unit 1A 4.
35. Swijnenburg, R. J., Schrepfer, S., Govaert, J. A., Cao, F., Ransohoff, K., Sheikh, A. Y., Haddad, M., Connolly, A. J., Davis, M. M., Robbins, R. C., and Wu, J. C. (2008). Immunosuppressive therapy mitigates immunological rejection of human embryonic stem cell xenografts. Proc. Natl. Acad. Sci. U.S.A. 105, 12991-12996.
36. Takahashi, K., Tanabe, K., Ohnuki, M., Narita, M., Ichisaka, T., Tomoda, K., and Yamanaka, S. (2007). Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell 131, 861-872.
37. Takahashi, K., and Yamanaka, S. (2006). Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell 126, 663-676.
38. Tang, C., Lee, A. S., Volkmer, J. P., Sahoo, D., Nag, D., Mosley, A. R., Inlay, M. A., Ardehali, R., Chavez, S. L., Pera, R. R., Behr, B., Wu, J. C., Weissman, I. L., and Drukker, M. (2011). An antibody against SSEA-5 glycan on human pluripotent stem cells enables removal of teratoma forming cells. Nat. Biotechnol. 29, 829-834.
39. Thomson, J. A., Itskovitz-Eldor, J., Shapiro, S. S., Waknitz, M. A., Swiergiel, J. J., Marshall, V. S., and Jones, J. M. (1998). Embryonic stem cell lines derived from human blastocysts. Science 282, 1145-1147.
40. Uchibori, R., Okada, T., Ito, T., Urabe, M., Mizukami, H., Kume, A., and Ozawa, K. (2009). Retroviral vector producing mesenchymal stem cells for targeted suicide cancer gene therapy. J. Gene Med. 11, 373-381.
41. Unger, C., Skottman, H., Blomberg, P., Dilber, M. S., and Hovatta, O. (2008). Good manufacturing practice and clinical-grade human embryonic stem cell lines. Hum. Mol. Genet. 17, R48-R53.
42. Walsh, P. T., Strom, T. B., and Turka, L. A. (2004). Routes to transplant tolerance versus rejection; the role of cytokines. Immunity 20, 121-131.
43. Yi, Y., Noh, M. J., and Lee, K. H. (2011). Current advances in retroviral gene therapy. Curr. Gene Ther. 11, 218-228.
44. Zhao, T., Zhang, Z. N., Rong, Z., and Xu, Y. (2011). Immunogenicity of induced pluripotent stem cells. Nature 474, 212-215.